Carna Biosciences has presented newly released MAPK Cascade Panel at the GloxoSmithKline Symposium 2005 held in Tsukuba, Japan.

Carna Biosciences has exhibited at Scientific Instruments Show Japan 2005, an exhibition for frontier of scientific technology information and latest scientific instruments held in Osaka, Japan and intruduced our latest products and services.

Carna Biosciences has presented newly released QuickScout™ MAPK Cascade Panel.
This conference is to evolve trends in kinase-based drug discovery and review of drug development platforms that promise to accelerate kinase-targeted therapeutics.

The MAPK cascade consist of more than 30 kinases, which are expected to participate in pathogenesis and development of various diseases, such as inflammatory diseases and cancer. Therefore, the inhibitors of MAPK cascade kinases are expected to be effective for treatment of these diseases.

QuickScout™ MAPK Cascade Panel is an useful drug discovery tool that are capable of profiling your compounds against 30 MAPK cascade members.

Carna Biosciences has exhibited at SBS held in Geneva, Switzerland and introduced our latest screening and profiling products and services.

Carna Biosciences has exhibited at Bio Japan 2005 held in Yokohama, Japan introducing our latest products and services and has presented at workshop.
Dr. Kohichiro Yoshino, President & CEO made speech on "Secrets of success as biotechnology venture company" and Dr. Hiroshi Ishiguro, CTO made speech on "Structual analysis on protein kinases".

Carna Biosciences has exhibited at 10th Drug Discovery Technology held in Boston, U.S. More than 200 companies has exhibited their cutting-edge technologies for drug discovery.

At our booth

[click to enlarge]

The Kansai Bureau of Economy, Trade and Industry (METI-KANSAI, a regional branch organization of the Ministry of Economy, Trade and Industry) has selected Carna Biosciences' project "research on comprehensive screening against kinases with unified platform" as one of medium, small and venture companies supporting programs.
Using microfluidic technologies, Carna Biosciences will develop comprehensive profiling panels to test activities of compounds against protein kinases.

Carna Biosciences has exhibited at BIO 2005 held in Philadelphia, U.S. and introduced our latest kinase products and services.

Carna Biosciences has exhibited at Protein Kinase Target, an exhibition focusing on kinase held in Boston, U.S.

Carna Biosciences has exhibited at Tri-Medicine 2005, an important landmark event that encompasses the entire spectrum of molecular medicine held in San Francisco, U.S.

At our booth

Carna Biosciences has exhibited at Screen Tech 2005, cutting-edge developments in kinase and GPCR targets, assay development and screening held in San Diego, U.S. We have released our latest service, profiling service "QuickScout ™ " series.

Posters at the booth

Carna Biosciences has presented screening technologies at ALA2005, the world's premier conference and exhibition on emerging laboratory technologies held in San Jose, US.
More than 300 companies from around the world have participated and we gained a high reputation from the participants.

Presented paper

"Structures and molecular recognitions of MARCKS family proteins", Mamoru Matsubara, was published in "Seikagaku", 2005 Jan.; 77(1)